A new study shows how an anticancer drug triggers an 'outside in' signal that gets it sucked ... design drugs that exploit this pathway to find and destroy cancer cells.

Thus, NKT cells and IL-13, possibly produced by NKT cells and signaling through the IL-4R–STAT6 pathway, are necessary for down-regulation of tumor immunosurveillance. IL-13 inhibitors may prove ...